| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/28/2004 | US20040214188 Diagnosis and treatment of diabetic , muscle, metabolic and eating disorders |
| 10/28/2004 | US20040214186 Method for identifying constitutively active mutants of mitogen activated protein kinase (mapk) and uses thereof |
| 10/28/2004 | US20040214181 Knockout reagent surrogate screening assay |
| 10/28/2004 | US20040214179 Breast cancer prognostics |
| 10/28/2004 | US20040214175 Solid phase technique for selectively isolating nucleic acids |
| 10/28/2004 | US20040214173 Anti-listeria bacteriocin |
| 10/28/2004 | US20040214172 Sheeplice, bovicola ovis, allergen treatment |
| 10/28/2004 | US20040214171 Cat kidney disease marker |
| 10/28/2004 | US20040214170 Method for effecting site-directed mutagenesis |
| 10/28/2004 | US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 10/28/2004 | US20040214162 Porcine adenoviral sequences comprising gene regulatory elements for use as tools in heterologous gene delivery and expression systems and preparation of genetic vaccines |
| 10/28/2004 | US20040214160 Using viruses to detect or purify proteins |
| 10/28/2004 | US20040214158 Treatment of human papillomavirus (hpv)-infected cells |
| 10/28/2004 | US20040214155 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 10/28/2004 | US20040213836 DRUG DELIVERY; prolonging the time a pharmaceutical drug circulates in the blood of a subject, comprising: introducing into the subject's bloodstream a pharmaceutical composition comprising a liposome containing inventive compound |
| 10/28/2004 | US20040213805 Deletions in arterivirus replicons |
| 10/28/2004 | US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide |
| 10/28/2004 | US20040213803 a polypeptide conjugated to a Streptococcus pneumoniae capsular polysaccharide; an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity; vaccine; genetic vaccine; antigen |
| 10/28/2004 | US20040213802 Gene of novel corynebacterium diphtheriae antigen |
| 10/28/2004 | US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry |
| 10/28/2004 | US20040213800 Active immunization to generate antibodies to soluble A-beta |
| 10/28/2004 | US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213795 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer |
| 10/28/2004 | US20040213794 Mst1 modulation of apoptosis in cardiac tissue and modultors of Mst1 for treatment and prevention of cardiac disease |
| 10/28/2004 | US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis |
| 10/28/2004 | US20040213791 Monoclonal antibodies; for diagnosis and treatment of prostate cell proliferative disorders; immunogens; immunotherapy; cell lines |
| 10/28/2004 | US20040213790 VEGF-related protein |
| 10/28/2004 | US20040213772 Peptide factor |
| 10/28/2004 | US20040213769 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 10/28/2004 | US20040213764 Adenovirus replication-competent vectors expressing trail |
| 10/28/2004 | US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3 |
| 10/28/2004 | US20040211511 Joining method |
| 10/28/2004 | CA2817265A1 Recombinant il-9 antibodies and uses thereof |
| 10/28/2004 | CA2522985A1 Means and methods for diagnosing and treating affective disorders |
| 10/28/2004 | CA2522802A1 Biologically active substance-immobilized device |
| 10/28/2004 | CA2522653A1 Methods of identifying spike morphology and fusarium head blight resistance, and the use of these methods for improving barley and related triticeae plants |
| 10/28/2004 | CA2522622A1 New process for improving the manufacture of clavams e.g. clavulanic acid |
| 10/28/2004 | CA2522618A1 Use of genes for increasing the oil content in plants |
| 10/28/2004 | CA2522597A1 Mouse deficient in glutamate transporter glast function |
| 10/28/2004 | CA2522552A1 Insulin-induced gene as therapeutic target in diabetes |
| 10/28/2004 | CA2522544A1 Process for isolating and purifing ovine hyaluronidase |
| 10/28/2004 | CA2522525A1 Chimeric polypeptides comprising a type ii restriction endonuclease |
| 10/28/2004 | CA2522332A1 Transformation of brassica |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2522054A1 Method for increrasing plant stress resistance by expression of a hos10 transcription factor in transgenic plants |
| 10/28/2004 | CA2521754A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 10/28/2004 | CA2521752A1 Plant cells and plants with increased tolerance to environmental stress |
| 10/28/2004 | CA2521674A1 Dna constructs and methods to enhance the production of commercially viable transgenic plants |
| 10/28/2004 | CA2521464A1 Irna conjugates |
| 10/28/2004 | CA2520518A1 Method for treatment of angiogenic disorders |
| 10/28/2004 | CA2463487A1 Tumours treating combinations, compositions and methods |
| 10/28/2004 | CA2463464A1 Methods of treatment and compositions therefor |
| 10/27/2004 | EP1471444A1 Rna sequence analyzer, and rna sequence analysis method, program and recording medium |
| 10/27/2004 | EP1471355A1 Method of fixing biomolecule to carrier |
| 10/27/2004 | EP1471154A2 Breast cancer prognostics |
| 10/27/2004 | EP1471152A1 Mutations in the human PCSK9 gene associated to hypercholesterolemia |
| 10/27/2004 | EP1471150A2 Plasmodium falciparum antigens inducing protective antibodies |
| 10/27/2004 | EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein |
| 10/27/2004 | EP1471146A2 A packaging cell line expressing for use in facilitating the development of high capacity adenoviral vectors |
| 10/27/2004 | EP1471145A2 Pesticipal proteins and strains |
| 10/27/2004 | EP1471144A1 Biological variability of asthma associated factor, AAF2 (IL-9 receptor), useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 10/27/2004 | EP1471143A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 10/27/2004 | EP1471142A1 Heterodimeric receptor libraries using phagemids |
| 10/27/2004 | EP1471141A1 Method for the production of resveratrol in cell cultures |
| 10/27/2004 | EP1471075A2 Human nucleic acid sequences expressed in pancreatic carcinomas |
| 10/27/2004 | EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents |
| 10/27/2004 | EP1470826A1 Decoy-containing pharmaceutical compositions and method of using the same |
| 10/27/2004 | EP1470422A2 Solid phases optimized for chemiluminescent detection |
| 10/27/2004 | EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470253A1 Device and method for thermal cycling |
| 10/27/2004 | EP1470252A2 Method for assembly of a polynucleotide encoding a target polypeptide |
| 10/27/2004 | EP1470251A2 Exponential amplification of nucleic acids using nicking agents |
| 10/27/2004 | EP1470250A2 Gene expression analysis using nicking agents |
| 10/27/2004 | EP1470249A2 Effectors of innate immunity |
| 10/27/2004 | EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 10/27/2004 | EP1470245A2 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 10/27/2004 | EP1470244A1 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 10/27/2004 | EP1470242A2 Enzymatic cycling assays for homocysteine and cystathionine |
| 10/27/2004 | EP1470240A2 Methods and compositions for treating cardiovascular disease using 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 21656, 32427, 2402, 7747,1720, 9151, 60491, 1371, 7077, 33207, 1419, 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165,2 |
| 10/27/2004 | EP1470239A2 Psoriasin expression by breast epithelial cells |
| 10/27/2004 | EP1470237A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 10/27/2004 | EP1470236A2 Methods and compositions for protein expression and purification |
| 10/27/2004 | EP1470233A1 Adenoviral vectors for modulating the cellular activities associated with pods |
| 10/27/2004 | EP1470232A1 Physiologically regulated erythropoietin-expressing vector for the treatment of anaemia |
| 10/27/2004 | EP1470231A2 Methods of obtaining isoform specific expression in mammalian cells |
| 10/27/2004 | EP1470230A1 Identification of characteristic specific genes of vegetal organisms |
| 10/27/2004 | EP1470229A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 10/27/2004 | EP1470228A2 Detection of mutations |
| 10/27/2004 | EP1470227A2 Method for overexpressing dehydrogenases |
| 10/27/2004 | EP1470226A1 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
| 10/27/2004 | EP1470225A1 Method of making libraries of anti-ligands |
| 10/27/2004 | EP1470224A1 Molecular libraries |
| 10/27/2004 | EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 10/27/2004 | EP1470222A2 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 10/27/2004 | EP1470221A1 Ralstonia ahl-acylase gene |
| 10/27/2004 | EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes |
| 10/27/2004 | EP1470161A1 Bispecific antibody dna constructs for intramuscular administration |